{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T21:10:31Z","timestamp":1753737031273,"version":"3.40.5"},"posted":{"date-parts":[[2023,8,21]]},"group-title":"In Review","reference-count":25,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T00:00:00Z","timestamp":1692576000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2023,8,4]]},"abstract":"<title>Abstract<\/title>\n        <p>Background\n\nJuvenile Dermatomyositis (JDM) is a rare autoimmune disease characterized by skin and muscle inflammation. The loss of nail fold capillary end row loops (ERL) is evidence of small vessel involvement in JDM. This study aimed to examine the association of ERL over the disease course and evidence of disease damage.\n\nMethods\n\nWe analyzed data from 68 initially treatment-na\u00efve JDM children who had been observed for at least five years with multiple ERL density assessments. The JDM disease courses were categorized into monocyclic short, monocyclic long, polycyclic, and chronic. The ERL capillary count was cumulatively evaluated using the area under the curve (AUC) method.\n\nResults\n\nThe mean ERL density for the treatment-naive JDM was significantly lower than that of their healthy controls (4.8\u00b11.6 \/mm vs. 7.9\u00b10.9 \/mm; p &lt;0.0001). The ERL AUC was significantly lower in children with chronic disease course compared to those with monocyclic short (p =0.001) or monocyclic long disease course (p =0.013). JDM patients with lipodystrophy had lower ERL AUC than those without lipodystrophy (p =0.04). There was no association between ERL AUC and calcifications or fractures.\n\nConclusion\n\nPersistently decreased ERL capillary density, evident by low ERL AUC, is associated with chronic disease course and lipodystrophy in JDM. Despite medical therapy, the mean ERL count remained below normal even after five years, particularly in polycyclic and chronic cases. Therefore, the goal of restoring normal capillary density in children with JDM might be challenging and require novel therapeutic strategies targeting their underlying endothelial dysfunction.<\/p>","DOI":"10.21203\/rs.3.rs-3235841\/v1","type":"posted-content","created":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T13:41:32Z","timestamp":1692625292000},"source":"Crossref","is-referenced-by-count":0,"title":["Juvenile Dermatomyositis: Association between Nail Fold Capillary End Row Loops Area Under the Curve and Disease Damage Indicators"],"prefix":"10.21203","author":[{"given":"Amer","family":"Khojah","sequence":"first","affiliation":[{"name":"Umm Al-Qura University College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4058-7112","authenticated-orcid":false,"given":"Gabrielle","family":"Morgan","sequence":"additional","affiliation":[{"name":"Ann and Robert H Lurie Children's Hospital of Chicago"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marisa S.","family":"Klein-Gitelman","sequence":"additional","affiliation":[{"name":"Ann and Robert H Lurie Children's Hospital of Chicago"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8117-574X","authenticated-orcid":false,"given":"Lauren M.","family":"Pachman","sequence":"additional","affiliation":[{"name":"Ann and Robert H Lurie Children's Hospital of Chicago"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s40674-020-00168-5","article-title":"Juvenile Dermatomyositis: New Clues to Diagnosis and Therapy","volume":"7","author":"Pachman LM","year":"2021","unstructured":"Pachman LM, Nolan BE, DeRanieri D, Khojah AM. Juvenile Dermatomyositis: New Clues to Diagnosis and Therapy. Curr Treatm Opt Rheumatol. 2021;7(1):39\u201362.","journal-title":"Curr Treatm Opt Rheumatol"},{"issue":"3","key":"ref2","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/art.11122","article-title":"US incidence of juvenile dermatomyositis, 1995\u20131998: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Registry","volume":"49","author":"Mendez EP","year":"2003","unstructured":"Mendez EP, Lipton R, Ramsey-Goldman R, Roettcher P, Bowyer S, Dyer A, et al. US incidence of juvenile dermatomyositis, 1995\u20131998: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Registry. Arthritis Rheum. 2003;49(3):300\u20135.","journal-title":"Arthritis Rheum"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jpeds.2017.12.053","article-title":"Advances in Juvenile Dermatomyositis: Myositis Specific Antibodies Aid in Understanding Disease Heterogeneity","volume":"195","author":"Pachman LM","year":"2018","unstructured":"Pachman LM, Khojah AM. Advances in Juvenile Dermatomyositis: Myositis Specific Antibodies Aid in Understanding Disease Heterogeneity. J Pediatr. 2018;195:16\u201327.","journal-title":"J Pediatr"},{"key":"ref4","doi-asserted-by":"crossref","DOI":"10.1016\/j.clicom.2023.02.007","article-title":"Lower NK Cell Numbers in Children with Untreated Juvenile Dermatomyositis During the COVID-19 Pandemic","author":"Costin C","year":"2023","unstructured":"Costin C, Morgan G, Khojah A, Klein-Gitelman M, Pachman LM. Lower NK Cell Numbers in Children with Untreated Juvenile Dermatomyositis During the COVID-19 Pandemic. Clin Immunol Commun. 2023.","journal-title":"Clin Immunol Commun"},{"issue":"7","key":"ref5","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/acr.24535","article-title":"Association of p155\/140 Autoantibody With Loss of Nailfold Capillaries but not Generalized Lipodystrophy: A Study of Ninety-Six Children With Juvenile Dermatomyositis","volume":"74","author":"Khojah A","year":"2022","unstructured":"Khojah A, Liu V, Savani SI, Morgan G, Shore R, Bellm J, et al. Association of p155\/140 Autoantibody With Loss of Nailfold Capillaries but not Generalized Lipodystrophy: A Study of Ninety-Six Children With Juvenile Dermatomyositis. Arthritis Care Res (Hoboken). 2022;74(7):1065\u20139.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"8","key":"ref6","first-page":"1644","article-title":"Skin involvement in juvenile dermatomyositis is associated with loss of end row nailfold capillary loops","volume":"31","author":"Smith RL","year":"2004","unstructured":"Smith RL, Sundberg J, Shamiyah E, Dyer A, Pachman LM. Skin involvement in juvenile dermatomyositis is associated with loss of end row nailfold capillary loops. J Rheumatol. 2004;31(8):1644\u20139.","journal-title":"J Rheumatol"},{"issue":"2","key":"ref7","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/art.23299","article-title":"Persistent association of nailfold capillaroscopy changes and skin involvement over thirty-six months with duration of untreated disease in patients with juvenile dermatomyositis","volume":"58","author":"Christen-Zaech S","year":"2008","unstructured":"Christen-Zaech S, Seshadri R, Sundberg J, Paller AS, Pachman LM. Persistent association of nailfold capillaroscopy changes and skin involvement over thirty-six months with duration of untreated disease in patients with juvenile dermatomyositis. Arthritis Rheum. 2008;58(2):571\u20136.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"ref8","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3390\/biomedicines11020552","article-title":"The von Willebrand Factor Antigen Reflects the Juvenile Dermatomyositis Disease Activity Score","volume":"11","author":"Gibbs EKA","year":"2023","unstructured":"Gibbs EKA, Morgan G, Ehwerhemuepha L, Pachman LM. The von Willebrand Factor Antigen Reflects the Juvenile Dermatomyositis Disease Activity Score. Biomedicines. 2023;11(2):552.","journal-title":"Biomedicines"},{"issue":"2","key":"ref9","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/art.23341","article-title":"Pharmacokinetic study of oral prednisolone compared with intravenous methylprednisolone in patients with juvenile dermatomyositis","volume":"59","author":"Rouster-Stevens KA","year":"2008","unstructured":"Rouster-Stevens KA, Gursahaney A, Ngai KL, Daru JA, Pachman LM. Pharmacokinetic study of oral prednisolone compared with intravenous methylprednisolone in patients with juvenile dermatomyositis. Arthritis Rheum. 2008;59(2):222\u20136.","journal-title":"Arthritis Rheum"},{"issue":"7","key":"ref10","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s00296-016-3467-6","article-title":"Calcinosis in juvenile dermatomyositis: frequency, risk factors and outcome","volume":"36","author":"Saini I","year":"2016","unstructured":"Saini I, Kalaivani M, Kabra SK. Calcinosis in juvenile dermatomyositis: frequency, risk factors and outcome. Rheumatol Int. 2016;36(7):961\u20135.","journal-title":"Rheumatol Int"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/MD.0b013e31816bc604","article-title":"Predictors of acquired lipodystrophy in juvenile-onset dermatomyositis and a gradient of severity","volume":"87","author":"Bingham A","year":"2008","unstructured":"Bingham A, Mamyrova G, Rother KI, Oral E, Cochran E, Premkumar A, et al. Predictors of acquired lipodystrophy in juvenile-onset dermatomyositis and a gradient of severity. Med (Baltim). 2008;87(2):70\u201386.","journal-title":"Med (Baltim)"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/art.10924","article-title":"Disease activity score for children with juvenile dermatomyositis: reliability and validity evidence","volume":"49","author":"Bode RK","year":"2003","unstructured":"Bode RK, Klein-Gitelman MS, Miller ML, Lechman TS, Pachman LM. Disease activity score for children with juvenile dermatomyositis: reliability and validity evidence. Arthritis Rheum. 2003;49(1):7\u201315.","journal-title":"Arthritis Rheum"},{"issue":"0 11","key":"ref13","first-page":"118","article-title":"Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient\/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)\/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), physician global damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI)","volume":"63","author":"Rider LG","year":"2011","unstructured":"Rider LG, Werth VP, Huber AM, Alexanderson H, Rao AP, Ruperto N, et al. Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient\/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)\/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), physician global damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI). Arthritis Care Res (Hoboken). 2011;63(0 11):118\u201357.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"ref14","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1093\/rheumatology\/keq407","article-title":"Nailfold capillary density is importantly associated over time with muscle and skin disease activity in juvenile dermatomyositis","volume":"50","author":"Schmeling H","year":"2011","unstructured":"Schmeling H, Stephens S, Goia C, Manlhiot C, Schneider R, Luthra S, et al. Nailfold capillary density is importantly associated over time with muscle and skin disease activity in juvenile dermatomyositis. Rheumatology (Oxford). 2011;50(5):885\u201393.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12969-017-0148-2","article-title":"Methods for analyzing observational longitudinal prognosis studies for rheumatic diseases: a review & worked example using a clinic-based cohort of juvenile dermatomyositis patients","volume":"15","author":"Lim LS","year":"2017","unstructured":"Lim LS, Pullenayegum E, Moineddin R, Gladman DD, Silverman ED, Feldman BM. Methods for analyzing observational longitudinal prognosis studies for rheumatic diseases: a review & worked example using a clinic-based cohort of juvenile dermatomyositis patients. Pediatr Rheumatol Online J. 2017;15(1):18.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"6","key":"ref16","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41584-023-00967-9","article-title":"Juvenile idiopathic inflammatory myositis: an update on pathophysiology and clinical care","volume":"19","author":"Papadopoulou C","year":"2023","unstructured":"Papadopoulou C, Chew C, Wilkinson MGL, McCann L, Wedderburn LR. Juvenile idiopathic inflammatory myositis: an update on pathophysiology and clinical care. Nat Rev Rheumatol. 2023;19(6):343\u201362.","journal-title":"Nat Rev Rheumatol"},{"issue":"7","key":"ref17","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.3899\/jrheum.181275","article-title":"Endothelial Activation Markers as Disease Activity and Damage Measures in Juvenile Dermatomyositis","volume":"47","author":"Kishi T","year":"2020","unstructured":"Kishi T, Chipman J, Evereklian M, Nghiem K, Stetler-Stevenson M, Rick ME, et al. Endothelial Activation Markers as Disease Activity and Damage Measures in Juvenile Dermatomyositis. J Rheumatol. 2020;47(7):1011\u20138.","journal-title":"J Rheumatol"},{"issue":"4","key":"ref18","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/rheumatology\/kex468","article-title":"Multiple target autoantigens on endothelial cells identified in juvenile dermatomyositis using proteomics","volume":"57","author":"Karasawa R","year":"2018","unstructured":"Karasawa R, Tamaki M, Sato T, Tanaka M, Nawa M, Yudoh K, et al. Multiple target autoantigens on endothelial cells identified in juvenile dermatomyositis using proteomics. Rheumatology (Oxford). 2018;57(4):671\u20136.","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"ref19","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jmii.2014.05.012","article-title":"Detection of anti-p155\/140, anti-p140, and antiendothelial cells autoantibodies in patients with juvenile dermatomyositis","volume":"49","author":"Yu HH","year":"2016","unstructured":"Yu HH, Chang HM, Chiu CJ, Yang YH, Lee JH, Wang LC, et al. Detection of anti-p155\/140, anti-p140, and antiendothelial cells autoantibodies in patients with juvenile dermatomyositis. J Microbiol Immunol Infect. 2016;49(2):264\u201370.","journal-title":"J Microbiol Immunol Infect"},{"issue":"13","key":"ref20","doi-asserted-by":"crossref","first-page":"10553","DOI":"10.3390\/ijms241310553","article-title":"Increased Otoferlin Expression in B Cells Is Associated with Muscle Weakness in Untreated Juvenile Dermatomyositis: A Pilot Study","volume":"24","author":"Bukhari A","year":"2023","unstructured":"Bukhari A, Khojah A, Marin W, Khramtsov A, Khramtsova G, Costin C, et al. Increased Otoferlin Expression in B Cells Is Associated with Muscle Weakness in Untreated Juvenile Dermatomyositis: A Pilot Study. Int J Mol Sci. 2023;24(13):10553.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s41927-022-00265-z","article-title":"Coding joint: kappa-deleting recombination excision circle ratio and B cell activating factor level: predicting juvenile dermatomyositis rituximab response, a proof-of-concept study","volume":"6","author":"Ochfeld E","year":"2022","unstructured":"Ochfeld E, Hans V, Marin W, Ahsan N, Morgan G, Pachman LM, et al. Coding joint: kappa-deleting recombination excision circle ratio and B cell activating factor level: predicting juvenile dermatomyositis rituximab response, a proof-of-concept study. BMC Rheumatol. 2022;6(1):36.","journal-title":"BMC Rheumatol"},{"issue":"1","key":"ref22","article-title":"Clues to Disease Activity in Juvenile Dermatomyositis: Neopterin and Other Biomarkers","volume":"12","author":"Khojah A","year":"2021","unstructured":"Khojah A, Morgan G, Pachman LM. Clues to Disease Activity in Juvenile Dermatomyositis: Neopterin and Other Biomarkers. Diagnostics (Basel). 2021;12(1).","journal-title":"Diagnostics (Basel)"},{"issue":"7","key":"ref23","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s11926-022-01076-4","article-title":"Update on Biomarkers of Vasculopathy in Juvenile and Adult Myositis","volume":"24","author":"McLellan K","year":"2022","unstructured":"McLellan K, Papadopoulou C. Update on Biomarkers of Vasculopathy in Juvenile and Adult Myositis. Curr Rheumatol Rep. 2022;24(7):227\u201337.","journal-title":"Curr Rheumatol Rep"},{"issue":"4","key":"ref24","first-page":"832","article-title":"Soluble adhesion molecules in pediatric rheumatic diseases","volume":"29","author":"Bloom BJ","year":"2002","unstructured":"Bloom BJ, Miller LC, Blier PR. Soluble adhesion molecules in pediatric rheumatic diseases. J Rheumatol. 2002;29(4):832\u20136.","journal-title":"J Rheumatol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.clicom.2023.06.001","article-title":"Nailfold capillary dropout precedes the presentation of pneumatosis intestinalis and micro-perforation in juvenile dermatomyositis","volume":"3","author":"Wang A","year":"2023","unstructured":"Wang A, Khojah A, Morgan G, Pachman LM. Nailfold capillary dropout precedes the presentation of pneumatosis intestinalis and micro-perforation in juvenile dermatomyositis. Clin Immunol Commun. 2023;3:74\u20136.","journal-title":"Clin Immunol Commun"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3235841\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3235841\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T15:53:03Z","timestamp":1700495583000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3235841\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,21]]},"references-count":25,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-3235841\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1186\/s12969-023-00919-3","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2023,8,21]]},"subtype":"preprint"}}